Inclusion Criteria:  Patients must have a confirmed diagnosis of IBD (either CD or UC) with moderate disease activity.) Ability to independently care for oneself  Exclusion Criteria:  Pregnancy Known HIV Patients receiving immunosuppressive drugs, other than for their bowel disease Patients must be on stable doses of their medications for the 2 weeks prior to study entry and for the duration of the treatment period, or inform the investigator of any changes in medication Active malignancy in the last 5 years Patients receiving any other investigational agent(s) Ginger allergy